What is the confirmatory test following initial imaging for pancreatic cancer?

• A. MRI
• B. Endoscopy guided biopsy
• C. Blood biomarkers
• D. Transabdominal ultrasound

Answer: (B)

The confirmatory test for pancreatic cancer following initial imaging is endoscopy-guided biopsy. This procedure allows for direct access to the pancreatic tissue, enabling pathologists to examine the cells for cancerous changes. While initial imaging such as a CT scan or MRI may suggest the presence of a tumor, a biopsy is essential for obtaining a definitive diagnosis.

Endoscopy-guided biopsy can be performed using techniques such as endoscopic ultrasound (EUS), which not only assists in the visualization of the pancreas but also helps in retrieving tissue samples from suspicious lesions. The ability to obtain cytological samples directly from the tumor site provides a high level of diagnostic accuracy, which is crucial for confirming pancreatic cancer and determining the appropriate management plan.

Other options, while important in the evaluation of pancreatic conditions, do not serve as definitive confirmatory tests. For example, blood biomarkers may support the diagnosis but aren't specific or sensitive enough to confirm pancreatic cancer on their own. Transabdominal ultrasound is useful for initial evaluation but lacks the specificity needed for confirmation. MRI can provide additional imaging details but is not the primary method for obtaining tissue for diagnosis.